In:
Blood, American Society of Hematology, Vol. 127, No. 15 ( 2016-04-14), p. 1847-1855
Abstract:
CRISPR-Cas9–mediated GGCX knockout cell–based assay clarifies the correlation between GGCX genotypes and their clinical phenotypes. A GGCX mutation decreases clotting factor carboxylation and abolishes MGP carboxylation, causing 2 distinct clinical phenotypes.
Type of Medium:
Online Resource
ISSN:
0006-4971
,
1528-0020
DOI:
10.1182/blood-2015-10-677633
Language:
English
Publisher:
American Society of Hematology
Publication Date:
2016
detail.hit.zdb_id:
1468538-3
detail.hit.zdb_id:
80069-7
Permalink